This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2. CM Nutting , JP Morden , KJ Harrington , TG Urbano , SA Bhide , C Clark Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127–36
3. MK Kam , SF Leung , B Zee , RM Chau , JJ Suen , F Mo Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873–9
5. JP Pignon , A le Maitre , E Maillard , J Bourhis , M-NC. Group Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4–14
8. JA Bonner , PM Harari , J Giralt , RB Cohen , CU Jones , RK Sur Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010;11:21–8
9. J Bernier , C Domenge , M Ozsahin , K Matuszewska , JL Lefèbvre , RH Greiner Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945–52
10. JS Cooper , Q Zhang , TF Pajak , AA Forastiere , J Jacobs , SB Saxman Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2012;84:1198–205
11. MR Posner , DM Hershock , CR Blajman , E Mickiewicz , E Winquist , V Gorbounova Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705–15